Energy Medicine Projects

Further elucidating and harnessing energetic mechanisms is the focus of this area of research, an initiative that may also reveal common mechanisms among all of the therapeutic modalities being explored by the Institute. For example, the Resonant Molecular Signaling (RMS) platform is one aspect of this overall effort. Work is underway to determine why the results of 14 successful FDA-authorized trials that focused on RMS agents consistently indicated adverse effects at levels commensurate with the negative responses of the placebo groups. In addition, practitioners have reported anecdotal evidence regarding the rapid transmission of these signals throughout the body. Independent researchers at the University of North Carolina at Chapel Hill have confirmed that the RMS anti-depressant works via different biopathways than current pharmaceuticals.

A common feature of RMS compared with biophotonic activity is that both pertain to regulatory mechanisms. Researchers at the International Institute of Biophysics regard biological regulatory functions as being dependent on this type of electromagnetic field that exists within the body.1 In turn, RMS molecules appear to act as regulatory signals or to initiate regulatory action through energetic means. Their use is based on the goal of restoring or maintaining homeodynamics in a manner that acts systemically and across spectra of diseases. Examples of this utility include the use of calmodulin to build bone mass for the treatment of osteoporosis and osteopenia, and the use of orexin to address both insomnia and narcolepsy. The overall regulation of bone tissue or of sleep is the target.

Our focus on the extracellular matrix may provide answers for determining shared mechanisms between RMS and bioenergy, but not necessarily related to meridian activity which is thought to be part of the matrix. While recent findings pertaining to meridians serve to show the potential of this area of energy medicine, there may be several mechanisms. Mounting scientific data pertaining to cellular communication gained by Institute investigators, for example, indicates which receptors are influenced and which genes are up- or down-regulated by specific molecules or fractions of molecules. Our work therefore complements other research pertaining to bioenergy.

To further our investigations regarding the nature of signaling, specific energy medicine projects include examining the effects of sound frequencies and varying wavelengths of light on genomic expression and cellular activity, and determining the biophotonic activity of therapeutic molecules and their effects on regulatory systems of the body.